European Active Surveillance Study of LCS12
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms EURAS_LCS12
- 25 Jan 2018 Planned End Date changed from 1 Jun 2021 to 1 Dec 2022.
- 25 Jan 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Feb 2022.
- 30 Aug 2017 Baseline characteristics results (n=26053, data cut off: Aug 2016) presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management